Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03157362 · ClinicalTrials.gov registry record · NA

Effects of Social Presence and Perception in Virtual Reality on Pain

A NA study, sponsored by Cornell University.

Completed
Registry status
NA
Development phase
105
Enrollment target

NCT03157362: Completed NA study, sponsored by Cornell University.

NCT03157362 is a NA study that has completed, run by Cornell University. The registered enrollment target is 105 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03157362, a NA study, has completed, sponsored by Cornell University.

COMPLETED
Registry status
NA
Development phase
105 participants
Enrollment target

Study Summary

This experiment aims to examine the effects of transportation via social presence in "near" and "far" virtual environments, on pain threshold in two groups: 1. healthy volunteers in an induced pain task, and 2. older adults suffering from pain. In the first, pilot group, a within-subjects study, participants will complete a series of induced-pain heat ramps in virtual environments that are "near" or "far"-in other words, they will either duplicate their actual physical environment, or represent another location. A second factor in this experiment will be mediated social presence, in which participants interact with confederates as avatars in either condition. The hypotheses follow: H1: Participants who feel present in a remote location will have a higher pain tolerance than those in a near location. H2: Participants who feel socially present with a confederate will have a higher pain tolerance than those who are alone in a virtual environment. H3: There will be an interaction between social presence and virtual environment such that participants who feel socially present in a remote location will have the highest pain tolerance overall. Building on these results,the next step will be a long-term study on older adult pain patients. In this step, the most successful condition in the first study to lightweight, portable headsets that can be used outside of the lab environment. This intervention will be tested on older adult patients who are suffering from chronic pain.

Primary Outcome

Change in temperature from the beginning to the end of each trial (when the heat ramp begins, and when participants remove their hands) will be noted in milliseconds.

Interventions

  • OTHER Near Non-Social
  • OTHER Near Social
  • OTHER Far Non-Social
  • OTHER Far Social

Trial Details

FieldValue
Enrollment Target 105 participants
Start Date 2018-02-01
Est. Completion 2018-11-08
Phase NA
Cornell University

66 total trials

What the finished NCT03157362 record still lists

NCT03157362 is an interventional study that assigns participants to a tested intervention. The registered 105 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower).

The record links to 0 conditions, and to 4 interventions - of which Near Non-Social is the first listed.

NCT03157362 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT03157362 about?

NCT03157362 is a clinical study titled "Effects of Social Presence and Perception in Virtual Reality on Pain". This experiment aims to examine the effects of transportation via social presence in "near" and "far" virtual environments, on pain threshold in two groups: 1. healthy volunteers in an induced pain task, and 2. older adults suffering from pain. In the first, pilot group, a within-subjects study, par...

What is the current status of trial NCT03157362?

This trial is currently completed. It is a NA study. The enrollment target is 105 participants. The study started on 2018-02-01. Estimated completion is 2018-11-08.

What interventions are being tested in trial NCT03157362?

The interventions under investigation include: Near Non-Social (OTHER), Near Social (OTHER), Far Non-Social (OTHER), Far Social (OTHER).

Who is sponsoring clinical trial NCT03157362?

This trial is sponsored by Cornell University, which has 66 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT03157362's enrollment target sits among peer trials

105 834th of 2000 higher than 1,165 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03372317 · 105 participants

    Tau PET in Imaging and Cognition: Healthy Adults From 55-90

  • NCT04253964 · 105 participants · Phase 2

    Pilot Study of Performance Status 2 vs. Performance Status 0-1 Non-small Cell Lung Cancer Patients Treated With Chemo/Immunotherapy

  • NCT04742452 · 105 participants · NA

    Comparison of Partial Rotator Cuff Repair vs. Superior Capsular Reconstruction for Irreparable Rotator Cuff Tears

  • NCT04875429 · 105 participants · NA

    Zenith® Fenestrated+ Clinical Study

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03157362, the US trial registry maintained by the National Library of Medicine. NCT03157362 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.